A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus

NCT07557927 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Discoid Lupus Erythematosus

Interventions

DRUG: Dihydroartemisinin tablets
DRUG: Dihydroartemisinin tablets
DRUG: Hydroxychloroquine tablets

Sponsor

Kunming Pharmaceuticals, Inc.